Arjuna Natural Poised to Take Stringent Action Against BCM-95 Curcumin Patent Infringement

KERALA, India–(BUSINESS WIRE)– Arjuna Natural Extracts Ltd, the sole inventor, manufacturer, and patent
owner of BCM-95^®, the bioavailable curcumin standardized for
curcuminoids that also contains turmeric essential oil and turmerones,
has announced their intent to take action against several U.S. companies
who are allegedly engaged in infringement of the company’s patents. The
product is available in the U.S. market through Dolcas Biotech LLC sales
associates.

The use of turmeric essential oil with turmerones when combined with
curcumin by any company without the expressed authorization of Arjuna
Natural is in violation of Arjuna’s U.S. patents. It has been discovered
that several companies in the United States are using turmeric essential
oils and turmerones in their curcumin formulations. Arjuna has announced
that if they do not cease and desist, they intend to take action to
protect their intellectual property rights.

Arjuna intends to fully protect their bioavailable curcumin invention
ingredients derived primarily from turmeric, having worked on this
effective formulation and delivery system technology since 2002.

« We will vigorously enforce and properly safeguard our intellectual
property rights, which include prohibiting the illegal use of our
patented invention,” said Dr. Benny Antony, Joint Managing Director of
Arjuna, the inventor of the formulation.

“The decision to take legal action against any company infringing our
patent will be seriously considered. We work on many research projects
each year that bring significant value addition to our existing product
portfolio. We will continue to invest in new technologies that answer
the ever-changing needs of our customers striving for various natural
health supplements. This also includes our commitment to diligently
guard our intellectual property,” Dr. Antony emphasized.

About Arjuna Natural Extracts

For more than 27 years, Arjuna Natural Extracts Ltd has been India’s
leading manufacturer and exporter of standardized botanical extracts for
pharmaceutical and nutraceutical industries. Established in 1989, the
company has grown in epic proportion with customers in 40 countries. The
company has 33 granted international patents to its credit, with the
majority commercialized globally. Arjuna’s advanced R&D unit is a
complete research facility for phytochemistry, pharmacokinetics,
formulation, development, and pre-clinical studies. Arjuna has R&D
partnerships with multiple international universities worldwide
fostering its research.

Arjuna has been in the forefront providing forward-looking, innovative
products and solutions in natural health food supplements. They provide
reliable, specialty natural solutions to enable their customers to meet
the needs of the health care business both today and tomorrow.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170424005170/en/